SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as a community-driven movement focused on reclaiming internet culture and the original meme ethos. Community members emphasize the power of unity and are actively building a culture around OG memes, setting it apart from current trends. Discussions highlight a return to the roots of internet humor and a rejection of perceived corporate influence.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community rallies around the "We're All Gonna Make It" mantra, expressing strong bullish sentiment. Talk centers on community support and shared success, particularly within the Solana ecosystem. Despite some bearish counter-chatter, holders show a strong commitment to the token.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amid discussions about its proposed acquisition of Northern Data and a significant advertising commitment from Tether, with community debates focusing on the potential benefits and dilution impact. Some investors express concerns about profitability, user growth, and management's execution, while others highlight the potential for growth in AI infrastructure and cloud services due to the deals. The stock's high short interest is also fueling speculation about a potential squeeze.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

The crypto token $SLAP is trending as the community rallies around the phrase "WAGMI" (We Are All Going To Make It), signaling strong collective support. Community members highlight the team's dedication and the ease of staking with instant withdrawals. There's also some discussion around connections to other tokens like $BROKE, $RAGE, and $SOL.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya is trending as investors discuss the potential impact of recent earnings beats, guidance raises, and high short interest, with some anticipating a significant short squeeze. The community is focused on the company's AI-driven credit analysis and potential for growth amid changing macroeconomic conditions. Some are concerned about the broader fintech sector and are keeping an eye on upcoming earnings.

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

Cogent Biosciences Inc

COGT is trending due to positive Phase 3 trial results for its GIST treatment, leading to a significant price surge. The community is buzzing about the potential for further upside, particularly given institutional ownership and the possibility of a short squeeze. Some traders are also weighing whether the news could lead to a buyout.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com ($MNDY) is trending as the community debates the stock's sharp decline despite a recent earnings beat and positive FY guidance. Some investors believe the sell-off is an overreaction, while others cite concerns about slowing growth and competition from AI-driven solutions. Community members are watching for a potential rebound around key support levels and discussing the impact of analyst ratings.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors await the European Medicines Agency's (EMA) decision on Blarcamesine, an Alzheimer's drug, with the community actively discussing potential outcomes and timelines. Community talking points include the drug's safety profile, efficacy compared to existing treatments, and possible short squeeze scenarios. Anticipation is building around the potential for a positive opinion, partnerships, and the overall impact on the Alzheimer's treatment landscape.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global ($VG) is trending due to a recent earnings report, which included a revenue beat but a cut to the FY25 adjusted EBITDA view. A new long-term sales agreement with Naturgy of Spain is also driving interest, with community discussion focused on the company's outlook, export capabilities, and the potential impact of EU gas storage levels.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics ($GALT) is trending as investors digest data presented at a recent conference, with community members highlighting the drug's potential impact on liver fibrosis and variceal development. Discussions revolve around the significance of biomarker data and potential synergies with GLP-1 therapies. The community speculates on potential buyout scenarios and the timing of key events, such as presentations at an upcoming liver meeting and a meeting with the FDA.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Beneficial Bancorp, Inc. operates as a bank holding company of Beneficial Bank, which engages in the provision of banking and financial services to individuals and small-to medium-sized businesses. It also offers commercial real estate, commercial business, one- to four-family real estate, consumer, home equity and constructions loans. The company was founded on August 14, 2014 and is headquartered in Philadelphia, PA.

Beneficial Bancorp Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$16.12
Prev Close	$16.16
Open	$16.05
Dividend Yield	1.68%
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	$0.65
Price to Book	N/A
Revenue Per Employee	$323,904.76
Enterprise Value/EBITDA	N/A

BNCL
Beneficial Mutual Bancorp Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest BNCL News

BNCLBeneficial Mutual Bancorp Inc.